{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:05:04Z","timestamp":1783400704716,"version":"3.54.6"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T00:00:00Z","timestamp":1194566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s10096-007-0413-2","type":"journal-article","created":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T07:29:55Z","timestamp":1194506995000},"page":"115-120","source":"Crossref","is-referenced-by-count":26,"title":["In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing"],"prefix":"10.1007","volume":"27","author":[{"given":"G.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Swanzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,9]]},"reference":[{"key":"413_CR1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/01.aids.0000180108.96135.25","volume":"19","author":"C Diego","year":"2005","unstructured":"Diego C, Ambrosioni JC, Abel G, Fernando B, Tom\u00e1s O, Ricardo N, Jorge B (2005) Disseminated nocardiosis caused by Nocardia abscessus in an HIV-infected patient: first reported case. AIDS 19:1330\u20131331","journal-title":"AIDS"},{"key":"413_CR2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/clinids\/13.4.624","volume":"13","author":"J Kim","year":"1991","unstructured":"Kim J, Minamoto GY, Grieco MH (1991) Nocardial infection as a complication of AIDS: report of six cases and review. Rev Infect Dis 13:624\u2013629","journal-title":"Rev Infect Dis"},{"key":"413_CR3","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2003) Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes, document M24-A. CLSI, Wayne, Pennsylvania"},{"key":"413_CR4","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/AAC.46.10.3337-3338.2002","volume":"46","author":"M Takei","year":"2002","unstructured":"Takei M, Fukuda H, Kishii R, Kadowaki Y, Atobe Y, Hosaka M (2002) Contribution of the C-8-methoxy group of gatifloxacin to inhibition of type II topoisomerases of Staphylococcus aureus. Antimicrob Agents Chemother 46:3337\u20133338","journal-title":"Antimicrob Agents Chemother"},{"key":"413_CR5","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/AAC.43.12.2969","volume":"43","author":"T Lu","year":"1999","unstructured":"Lu T, Zhao X, Drlica K (1999) Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group. Antimicrob Agents Chemother 43:2969\u20132974","journal-title":"Antimicrob Agents Chemother"},{"key":"413_CR6","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/JCM.41.4.1705-1709.2003","volume":"41","author":"S Pottumarthy","year":"2003","unstructured":"Pottumarthy S, Limaye AP, Prentice JL, Houze YB, Swanzy SR, Cookson BT (2003) Nocardia veterana, a new emerging pathogen. J Clin Microbiol 41:1705\u20131709","journal-title":"J Clin Microbiol"},{"key":"413_CR7","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2007) Performance standards for antimicrobial susceptibility testing, document MS100-S17. CLSI, Wayne, Pennsylvania"},{"key":"413_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/CMR.19.2.259-282.2006","volume":"19","author":"BA Brown-Elliott","year":"2006","unstructured":"Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr (2006) Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 19:259\u2013282","journal-title":"Clin Microbiol Rev"},{"key":"413_CR9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1469-0691.2006.01460.x","volume":"12","author":"Y Glupczynski","year":"2006","unstructured":"Glupczynski Y, Berhin C, Janssens M, Wauters G (2006) Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect 12:905\u2013912","journal-title":"Clin Microbiol Infect"},{"key":"413_CR10","volume-title":"Automated procedures for antimicrobial susceptibility tests","author":"C Thornsberry","year":"1980","unstructured":"Thornsberry C, Gavan TL (1980) Automated procedures for antimicrobial susceptibility tests. American Society for Microbiology, Washington, DC"},{"key":"413_CR11","volume-title":"Evaluation of automated and rapid methods","author":"JC Sherris","year":"1982","unstructured":"Sherris JC, Ryan KJ (1982) Evaluation of automated and rapid methods. American Society for Microbiology, Washington, DC"},{"key":"413_CR12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/AAC.42.4.956","volume":"42","author":"X Zhao","year":"1998","unstructured":"Zhao X, Wang JY, Xu C, Dong Y, Zhou J, Domagala J, Drlica K (1998) Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones. Antimicrob Agents Chemother 42:956\u2013958","journal-title":"Antimicrob Agents Chemother"},{"key":"413_CR13","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/AAC.45.6.1649-1653.2001","volume":"45","author":"H Fukuda","year":"2001","unstructured":"Fukuda H, Kishii R, Takei M, Hosaka M (2001) Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae. Antimicrob Agents Chemother 45:1649\u20131653","journal-title":"Antimicrob Agents Chemother"},{"key":"413_CR14","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JCM.28.12.2726-2732.1990","volume":"28","author":"RJ Wallace Jr","year":"1990","unstructured":"Wallace RJ Jr, Tsukamura M, Brown BA, Brown J, Steingrube VA, Zhang YS, Nash DR (1990) Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol 28:2726\u20132732","journal-title":"J Clin Microbiol"},{"key":"413_CR15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JCM.35.4.847-852.1997","volume":"35","author":"A Ambaye","year":"1997","unstructured":"Ambaye A, Kohner PC, Wollan PC, Roberts KL, Roberts GD, Cockerill FR 3rd (1997) Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex. J Clin Microbiol 35:847\u2013852","journal-title":"J Clin Microbiol"},{"key":"413_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0732-8893(94)90120-1","volume":"19","author":"JR Biehle","year":"1994","unstructured":"Biehle JR, Cavalieri SJ, Saubolle MA, Getsinger LJ (1994) Comparative evaluation of the E test for susceptibility testing of Nocardia species. Diagn Microbiol Infect Dis 19:101\u2013110","journal-title":"Diagn Microbiol Infect Dis"},{"key":"413_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0732-8893(01)00273-5","volume":"40","author":"P Tomlin","year":"2001","unstructured":"Tomlin P, Sand C, Rennie RP (2001) Evaluation of E test, disk diffusion and broth microdilution to establish tentative quality control limits and review susceptibility breakpoints for two aerobic actinomycetes. Diagn Microbiol Infect Dis 40:179\u2013186","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-007-0413-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-007-0413-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:49:12Z","timestamp":1588031352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-007-0413-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,9]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1007\/s10096-007-0413-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,9]]}}}